Drugs Made In America Acquisition Corp

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Drugs Made In America Acquisition Corp had 14.89K in cash and cash equivalents.

Drugs Made In America Acquisition Corp reported 7.28M in total liabilities as of the latest reported quarter, including 376.17K in current liabilities and 6.90M in non-current liabilities.

As of the latest reported quarter, Drugs Made In America Acquisition Corp's total assets were 239.92M, consisting of 12.19K in current assets and 239.91M in non-current assets.

Drugs Made In America Acquisition Corp reported 232.64M in total shareholders' equity as of the latest reported quarter.